Avoro Capital Advisors LLC reports

Company location: New York, NY
Fiscal year end: 31 December

Avoro Capital Advisors LLC has filed 312 SEC EDGAR filings since 13 Feb 2015

Filter by type:
SC13D
SC13G

SEC filing history

Showing 51-75 of 140 matching filings.

Per page

25

Current page

3

SC 13G/A

IOVANCE BIOTHERAPEUTICS, INC.

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ADVERUM BIOTECHNOLOGIES, INC.

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

POINT BIOPHARMA GLOBAL INC.

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

RELMADA THERAPEUTICS, INC.

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

FENNEC PHARMACEUTICALS INC.

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ARENA PHARMACEUTICALS, INC.

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ARENA PHARMACEUTICALS, INC.

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

PMV PHARMACEUTICALS, INC.

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

MONTE ROSA THERAPEUTICS, INC.

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

SC 13G filing

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

IO BIOTECH, INC.

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

APELLIS PHARMACEUTICALS, INC.

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

IOVANCE BIOTHERAPEUTICS, INC.

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MADRIGAL PHARMACEUTICALS, INC.

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

CYMABAY THERAPEUTICS, INC.

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

UNITED THERAPEUTICS CORPORATION

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ADVERUM BIOTECHNOLOGIES, INC.

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MARINUS PHARMACEUTICALS, INC.

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MIRATI THERAPEUTICS, INC.

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

XENON PHARMACEUTICALS, INC.

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MARINUS PHARMACEUTICALS, INC.

Filing date: 12 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

XENON PHARMACEUTICALS, INC.

Filing date: 12 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

KARYOPHARM THERAPEUTICS INC.

Filing date: 12 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

CUE BIOPHARMA, INC.

Filing date: 12 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ATHENEX, INC.

Filing date: 12 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .